A cultured breast cancer cell starts to migrate outwards (Image: Steve Gschmeissner/Science Photo Library)
AS THE US faces up to its “fiscal cliff” of massive spending cuts, a major issue is burgeoning health costs. High on the list of those costs is cancer therapy, with the clamour for hugely expensive drugs – many of which have little or no clinical benefit – set to grow as baby boomers age.
Cancer research swallows billions of dollars a year, but the life expectancy for someone diagnosed with cancer that has spread to other parts of the body has changed little over several decades. Therapy…
